Cresco Labs OTC (TSE:CL) has released an update.
Cresco Labs Inc. has reported strong financial results for the fourth quarter and full year of 2023, highlighting a 3x increase in Operating Cash Flow and nearly doubled adjusted EBITDA. Despite a slight 2% dip in Q4 revenue, the company has shown significant profitability, with impressive year-over-year improvements in gross profit and a reduction in SG&A expenses as a result of its Year-of-the-Core strategy. Additionally, Cresco Labs has maintained its leading market position in several states, ending the year with substantial cash reserves.
For further insights into TSE:CL stock, check out TipRanks’ Stock Analysis page.
